IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,807,574 | -8.2% | 1,496,170 | +42.1% | 0.04% | -4.8% |
Q2 2023 | $7,412,564 | +10.7% | 1,052,921 | -3.9% | 0.04% | -6.7% |
Q1 2023 | $6,693,132 | -10.1% | 1,095,439 | -6.0% | 0.04% | -27.4% |
Q4 2022 | $7,448,810 | +25.7% | 1,165,698 | +88.4% | 0.06% | -1.6% |
Q3 2022 | $5,927,000 | +16.7% | 618,685 | +34.5% | 0.06% | +34.0% |
Q2 2022 | $5,079,000 | -24.8% | 460,080 | +13.4% | 0.05% | +17.5% |
Q1 2022 | $6,755,000 | +23.9% | 405,708 | +42.1% | 0.04% | +37.9% |
Q4 2021 | $5,450,000 | +61.5% | 285,506 | +108.6% | 0.03% | +26.1% |
Q3 2021 | $3,375,000 | +16.6% | 136,857 | +23.0% | 0.02% | +27.8% |
Q2 2021 | $2,894,000 | -4.8% | 111,235 | +15.8% | 0.02% | -14.3% |
Q1 2021 | $3,041,000 | +251.2% | 96,049 | +414.6% | 0.02% | +162.5% |
Q4 2020 | $866,000 | -58.0% | 18,663 | -70.2% | 0.01% | -68.0% |
Q3 2020 | $2,061,000 | +132.1% | 62,592 | +93.4% | 0.02% | +92.3% |
Q2 2020 | $888,000 | +144.6% | 32,365 | +166.9% | 0.01% | -13.3% |
Q1 2020 | $363,000 | -87.3% | 12,128 | -88.2% | 0.02% | -65.9% |
Q4 2019 | $2,851,000 | -35.2% | 102,990 | -57.4% | 0.04% | -36.2% |
Q3 2019 | $4,398,000 | +86.1% | 241,660 | +150.7% | 0.07% | +64.3% |
Q2 2019 | $2,363,000 | +67.4% | 96,386 | -35.1% | 0.04% | +82.6% |
Q1 2019 | $1,412,000 | – | 148,437 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |